Medical Marijuana Update
The Republican platform committee rejects medical marijuana, medical marijuana research issues get a hearing in the Senate, Arkansas will vote on at least one medical marijuana initiative this Fall — maybe 2 — and more.
NationalOn Monday, the GOP rejected a medical marijuana platform plank. Republican delegates meeting Monday in Cleveland ahead of the party’s national convention voted against endorsing medical marijuana in their party platform. The vote came after contentious debate, with some delegates making claims about cannabis reminiscent of Reefer Madness. One delegate claimed people who commit mass murders are “young boys from divorced families, and they’re all smoking pot,” another compared medical marijuana to physically addictive and potentially lethal prescription opiates. Still, it took two voice votes for the measure to be voted down.
On Tuesday, a Senate subcommittee held a hearing on medical marijuana research. The US Senate Judiciary Subcommittee on Crime and Terrorism held the hearing on “Researching the Potential Medical Benefits and Risks of Marijuana.” Testimony was heard from Sens. Kirsten Gillibrand (D-NY) and Cory Booker (D-NJ), who are original co-sponsors of medical marijuana legislation introduced last year in the Senate known as the Compassionate Access, Research Expansion, and Respect States (CARERS) Act (S 683). Other scheduled included officials from the National Institute on Drug Abuse (NIDA) and the Food and Drug Administration (FDA), among others.
Also on Tuesday, Senators Feinstein and Grassley called for expedited evaluation of the medical uses of CBD. The two Senate octogenarians have asked Attorney General Loretta Lynch and Health and Human Services Director Sylvia Burwell for the two agencies to work together to remove barriers to the scientific and medical evaluation of cannabidiol (CBD). The pair, who are, respectively, the co-Chair and Chair of the Senate Caucus on International Narcotics Control, made their request in a letter to the two agency heads.
Last Tuesday, the Arkansas Medical Cannabis Act qualified for the November ballot. Arkansans for Compassionate Care (ACC) has collected enough valid voter signatures to qualify its medical marijuana initiative for the November ballot, Secretary of State Mack Martin confirmed. A second initiative, the Arkansas Medical Marijuana Amendment, has yet to qualify for the ballot, and ACC is calling on its organizers to end their campaign and join forces.
Last Friday, supporters of the Arkansas Medical Marijuana Amendment handed in signatures. Backers of a proposed constitutional amendment to allow medical marijuana turned in more than 106,000 signatures to state officials, the last day for turn-ins. They need nearly 85,000 valid voter signatures, so this is going to be a nail-biter. Earlier this week, a competing medical marijuana initiative from Arkansans for Compassionate Care qualified for the ballot.
On Tuesday, the Health Department came out against the medical marijuana initiatives. The state Department of Health said in a statement that it opposed such initiatives because marijuana is not approved by the federal Food and Drug Administration and its legalization by popular vote is not grounded in “rigorous” science. A medical marijuana initiative from Arkansans for Compassionate Care has already qualified for the ballot, and the Arkansas Medical Marijuana Amendment has handed in some 106,000 signatures. It needs 85,000 valid ones to qualify.
Last Tuesday, the San Bernardino city council voted to put a dispensary regulatory system before the voters. The city council voted to put the measure on the November ballot even though a majority disapproves of it. Their hand was forced by a petition campaign that gathered more than 6,000 voter signatures. A second, competing proposal may also make the ballot.
Also last Tuesday, a Long Beach dispensary initiative qualified for the November ballot. City Clerk Maria de la Luz Garcia announced that an initiative to allow dispensaries has qualified for the November ballot. A city council member may try to add another ballot measure that would allow dispensaries, but with more restrictions.
On Monday, officials reported climbing medical marijuana sales. The state saw $2.57 million in medical marijuana sales in June, up from $2.3 million in May, according to figures from the state Department of Agriculture. Sales total $13.8 million since the first dispensaries started operating last November. The numbers should increase even further once two new qualifying conditions — PTSD and terminal illness — come on line. They have already been approved, but the Department of Health is in the midst of preparing new rules and application forms.
On Tuesday, Mthe state rejected including opiate addiction as a qualifying condition for medical marijuana. The administration of Tea Party Gov. Paul LePage (R) has rejected a petition seeking to include opiate addiction on the state’s list of qualifying conditions for medical cannabis. State officials said the case for inclusion was “compelling,” but they also said human studies hadn’t been done and more research was needed.
On Monday, a medical marijuana initiative campaign handed in signatures. The North Dakotans for Compassionate Care campaign handed in some 15,500 raw signatures for its medical marijuana initiative Monday, the last day for handing them in. The campaign needs 13,452 valid voter signatures to qualify, so there is very little cushion for invalidated signatures. Stay tuned.
On Wednesday, word came that the initiative campaign actually handed in 17,000 signatures. The North Dakotans for Compassionate Care campaign actually handed in some 17,000 raw signatures for its medical marijuana initiative Monday. Earlier reports had the number at 15,500. It’s still going to a nail-biter to see if it qualifies for the ballot; it needs 13,452 valid voter signatures.
(For extensive information about the medical marijuana debate, presented in a neutral format, visit MedicalMarijuana.ProCon.org.)
By Phillip Smith
Paul Ebeling, Editor
Latest posts by Paul Ebeling (see all)
- Key Stock Indexes, Crude, Gold & Silver Markets Briefing - February 21, 2017
- Commentary: Paul Ebeling on Wall Street - February 21, 2017
- Wall Street’s Top Analysts Upgrades, Downgrades & Initiations - February 21, 2017